2025 Compounding Drug Development 
pharmaphorum
NOVEMBER 9, 2022
Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 Currently, the time needed for a drug to reach the market ranges from 12 to 18 years, with an average cost of about $2.6 The Pharma.AI
pharmaphorum
AUGUST 17, 2022
Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five new drug targets — and possibly spending more than a billion in milestone payments and tiered royalties when all is said and done. Additional payments will be tied to specific research, development, and sales milestones.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 5, 2023
GlobalData’s latest report, ‘Myelofibrosis: Eight-Market Drug Forecast and Market Analysis,’ reveals that the MF market will grow from $2.39 billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 billion in 2021 to $2.89 per cent, driven by the approvals of nine pipeline agents.
Express Pharma
SEPTEMBER 24, 2023
The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR). This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA. billion in sales in 2029.
Express Pharma
JULY 10, 2024
With advancements in biotechnology, robust scientific capabilities, cost-effective manufacturing processes, a large workforce and a shift towards more complex biologic drugs, India is at the cusp of a huge opportunity to emerge as a leader in biopharma. On a monthly basis, this market adds around $1.16
STAT
DECEMBER 2, 2024
But over the last couple of years, there’s been a surge of interest in a new type of treatment , one that is testing drug developers and health care practitioners alike. Jefferies analysts estimate that there will be more activity 2025. Continue to STAT+ to read the full story…
Pharmaceutical Technology
MARCH 22, 2023
Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. From 2025, it will be substituted with a new chapter on functional tests for the complete system.”
Expert insights. Personalized for you.
111 
Let's personalize your content